Article
Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung.
JPMA. The Journal of the Pakistan Medical Association - 1 Nov 2019
Nisaa Zia Noor Un, Khokhar Mohammad Abbas, Qamar Samina, Hanif Asif, Goraya Ali Waheed, Awan Nukhbat Ullah
Abstract excerpt
OBJECTIVE: To assess the efficacy and tolerability of erlotinib in combination with radiation therapy followed by maintenance therapy in Stage III and IV, epidermal growth factor receptor mutationpositive adenocarcinoma lung patients. METHODS: The single-arm, quasi-experimental study was conducted at the Mayo Hospital, Lahore, Pakistan, from September 2013 to December 2014, and comprised patients with lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.